Cancer Antigen 125 in Patients With Chronic Liver Disease
- 1 June 2002
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (6) , 538-541
- https://doi.org/10.4065/77.6.538
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Markedly Elevated CA125 in Hepatic CirrhosisJournal of Clinical Gastroenterology, 1999
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- Serum CA 125 levels during the menstrual cycleBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Serum CA 125 in acute pelvic inflammatory diseaseBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive SystemThe Lancet Healthy Longevity, 1986
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973